Abstract

The pathogenesis of thyroid dysgenesis (TD) is not well understood. Here, using a combination of single-cell RNA and spatial transcriptome sequencing, we identify a subgroup of NF-κB-activated thyrocytes located at the center of thyroid tissues in postnatal mice, which maintained a partially mesenchymal phenotype. These cells actively protruded out of the thyroid primordium and generated new follicles in zebrafish embryos through continuous tracing. Suppressing NF-κB signaling affected thyrocyte migration and follicle formation, leading to a TD-like phenotype in both mice and zebrafish. Interestingly, during thyroid folliculogenesis, myeloid cells played a crucial role in promoting thyrocyte migration by maintaining close contact and secreting TNF-α. We found that cebpa mutant zebrafish, in which all myeloid cells were depleted, exhibited thyrocyte migration defects. Taken together, our results suggest that myeloid-derived TNF-α-induced NF-κB activation plays a critical role in promoting the migration of vertebrate thyrocytes for follicle generation.

The mechanism underlying thyroid follicle formation is not well understood. Here, the authors show that a subgroup of NF-κB-activated thyrocytes, through interactions with myeloid cells, exhibit increased migration capacity to generate new follicles.

Details

Title
Myeloid cells interact with a subset of thyrocytes to promote their migration and follicle formation through NF-κB
Author
Yang, Rui-Meng 1 ; Song, Shi-Yang 1 ; Wu, Feng-Yao 1 ; Yang, Rui-Feng 2   VIAFID ORCID Logo  ; Shen, Yan-Ting 3   VIAFID ORCID Logo  ; Tu, Ping-Hui 1 ; Wang, Zheng 1 ; Zhang, Jun-Xiu 4 ; Cheng, Feng 5 ; Gao, Guan-Qi 6 ; Liang, Jun 7 ; Guo, Miao-Miao 1 ; Yang, Liu 1 ; Zhou, Yi 8 ; Zhao, Shuang-Xia 1   VIAFID ORCID Logo  ; Zhan, Ming 3 ; Song, Huai-Dong 1   VIAFID ORCID Logo 

 Shanghai Jiao Tong University School of Medicine, Department of Molecular Diagnostics & Endocrinology, Shanghai Ninth People’s Hospital, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293) 
 Shanghai Medical College, Fudan University, Department of Oncology, Shanghai, China (GRID:grid.11841.3d) (ISNI:0000 0004 0619 8943) 
 Shanghai Jiao Tong University School of Medicine, Department of Urology, Shanghai Ninth People’s Hospital, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293) 
 Maternal and Child Health Institute of Bozhou, Department of Endocrinology, Bozhou, China (GRID:grid.16821.3c) 
 Fujian Medical University, Department of Laboratory Medicine, Fujian Children’s Hospital, Fuzhou, China (GRID:grid.256112.3) (ISNI:0000 0004 1797 9307) 
 The Linyi People’s Hospital, Department of Endocrinology, Linyi, China (GRID:grid.415946.b) (ISNI:0000 0004 7434 8069) 
 The Central Hospital of Xuzhou Affiliated to Xuzhou Medical College, Department of Endocrinology, Xuzhou, China (GRID:grid.417303.2) (ISNI:0000 0000 9927 0537) 
 Boston Children’s Hospital and Harvard Stem Cell Institute, Stem Cell Program, Boston, USA (GRID:grid.511171.2); Boston Children’s Hospital and Dana Farber Cancer Institute, Division of Hematology/Oncology, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438) 
Pages
8082
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2898759159
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.